<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Treating Treatment-Resistant Patients with Panic Disorder and Agoraphobia Using Psychotherapy: A Randomized Controlled Switching Trial</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-02-21">February 21, 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>PhD</roleName><forename type="first">Andrew</forename><forename type="middle">T</forename><surname>Gloster</surname></persName>
							<email>andrew.gloster@unibas.ch</email>
							<affiliation key="aff0">
								<orgName type="department">Institute of Clinical Psychology and Psychotherapy</orgName>
								<orgName type="institution">Technische Universität Dresden</orgName>
								<address>
									<settlement>Dresden</settlement>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Division of Clinical Psychology and Epidemiology</orgName>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Department of Psychology</orgName>
								<orgName type="institution">University of Basel</orgName>
								<address>
									<settlement>Basel</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Rainer</forename><surname>Sonntag</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Private Practice</orgName>
								<address>
									<settlement>Olpe</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jürgen</forename><surname>Hoyer</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Clinical Psychology and Psychotherapy</orgName>
								<orgName type="institution">Technische Universität Dresden</orgName>
								<address>
									<settlement>Dresden</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andrea</forename><forename type="middle">H</forename><surname>Meyer</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Division of Clinical Psychology and Epidemiology</orgName>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Department of Psychology</orgName>
								<orgName type="institution">University of Basel</orgName>
								<address>
									<settlement>Basel</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Simone</forename><surname>Heinze</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Clinical Psychology and Psychotherapy</orgName>
								<orgName type="institution">Technische Universität Dresden</orgName>
								<address>
									<settlement>Dresden</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andreas</forename><surname>Ströhle</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Georg</forename><surname>Eifert</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Department of Psychology</orgName>
								<orgName type="institution">Chapman University</orgName>
								<address>
									<settlement>Orange</settlement>
									<region>Calif</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Hans-Ulrich</forename><surname>Wittchen</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Clinical Psychology and Psychotherapy</orgName>
								<orgName type="institution">Technische Universität Dresden</orgName>
								<address>
									<settlement>Dresden</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="department">Division of Clinical Psychology and Epidemiology Department of Psychology</orgName>
								<orgName type="institution">University of Basel Missionsstrasse 62A</orgName>
								<address>
									<postCode>CH-4055</postCode>
									<settlement>Basel</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Treating Treatment-Resistant Patients with Panic Disorder and Agoraphobia Using Psychotherapy: A Randomized Controlled Switching Trial</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-02-21">February 21, 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">0050CC19D2D743100A24650E4EDC8958</idno>
					<idno type="DOI">10.1159/000370162</idno>
					<note type="submission">Received: May 21, 2014 Accepted after revision: November 23, 2014 Received post (n = 28) Received post (n = 8 Received FU (n = 27* Received FU (n = 7</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:29+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Nonresponders</term>
					<term>Treatment-resistant patients</term>
					<term>Therapy switching</term>
					<term>Acceptance and commitment therapy</term>
					<term>Panic disorder</term>
					<term>Agoraphobia</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>on the waiting list, while improvement on the MI (d = 0.50) was nearly significant.</s><s>Secondary outcomes were consistent with ACT theory.</s><s>Follow-up assessments indicated a stable and continued improvement after treatment.</s><s>The dropout rate was low (9%).</s><s>Conclusions: Despite a clinically challenging sample and brief treatment administered by novice therapists, patients who received ACT reported significantly greater changes in functioning and symptomatology than those on the waiting list, with medium-to-large effect sizes that were maintained for at least 6 months.</s><s>These proof-ofprinciple data suggest that ACT is a viable treatment option for treatment-resistant PD/A patients.</s><s>Further work on switching to psychotherapy for nonresponders is clearly needed.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Nonresponsiveness to treatment is generally acknowledged as a considerable problem, with estimates ranging from 25 to 50% of patients who complete state-of-the-art treatments.</s><s>Even in the case of anxiety disorders, which are generally considered to respond favorably to cognitive-behavioral treatment (CBT) <ref type="bibr" target="#b0">[1]</ref> , more than 20% of patients do not reach the criteria for high end-state functioning.</s><s>These estimates do not include patients that drop 101 out or remain impaired despite some measurable improvement <ref type="bibr" target="#b1">[2]</ref> .</s></p><p><s>Empirical studies on treatment-resistant patients are rare <ref type="bibr" target="#b2">[3,</ref><ref type="bibr" target="#b3">4]</ref> , and empirically based guidelines to advise clinicians on how to help treatment nonresponders are lacking.</s><s>Very few randomized controlled trials have examined the effects of switching from a psychotherapy that failed to adequately work to a different psychotherapy.</s><s>Instead, most treatment-refractory studies are pharmacological in nature, both in terms of the original treatment and the alternative response <ref type="bibr" target="#b4">[5]</ref> .</s><s>Even when psychological treatments are examined, they are usually administered either directly following or in combination with pharmacology <ref type="bibr" target="#b5">[6]</ref> .</s><s>The problem of nonresponse is particularly challenging when state-of-the-art psychological interventions fail, such as CBT for patients with panic disorder and agoraphobia.</s><s>Evidence exists that continued exposure can help in some cases <ref type="bibr" target="#b6">[7]</ref> .</s><s>A recent study <ref type="bibr" target="#b7">[8]</ref> also addressed this issue in a multisite randomized controlled clinical trial of patients with primary panic disorder and/or agoraphobia (PD/A).</s><s>These authors examined whether the addition of 9 monthly maintenance ('booster') sessions would increase the likelihood of sustained improvement and reduced relapse.</s><s>Indeed, beyond maintenance of improvements, they also observed symptom reduction in previous nonresponders.</s></p><p><s>The systematic examination of treatment in nonresponders and the treatment development in general have been impeded by the disproportionate concentration on comparing the efficacy of various treatments <ref type="bibr" target="#b8">[9]</ref> .</s><s>Trials on groups of patients with specific characteristics, such as failed treatment <ref type="bibr" target="#b9">[10]</ref> and close examinations of processes, are needed.</s><s>Examining the mechanisms of action of treatment has only recently become the focus of randomized controlled trials (RCTs) <ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref> .</s><s>Outside of this focus on positive effects remains the important challenge of what to do for the sizeable minority who do not respond to treatment, which is a pressing demand that has been acknowledged in efforts to formulate clinical approaches to sequential treatment <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b14">15]</ref> .</s></p><p><s>Acceptance and commitment therapy (ACT) is a cognitive-behavioral therapy that teaches psychological concepts, such as mindfulness, acceptance, cognitive defusion (flexible distancing from the literal meaning of cognitions), and other strategies to increase psychological flexibility and promote behavior change consistent with personal values.</s><s>Within ACT, psychological flexibility is defined as the capacity to make contact with experience in the present moment, and -based on what is possible in that moment -to persist in or change behav-ior in the pursuit of goals and values <ref type="bibr" target="#b15">[16,</ref><ref type="bibr" target="#b25">26]</ref> .</s><s>Clinical studies and RCTs provide evidence that ACT is effective for a wide array of disorders <ref type="bibr" target="#b16">[17]</ref> , including primary treatment for anxiety disorders, such as social anxiety disorder <ref type="bibr" target="#b17">[18]</ref> , panic disorder <ref type="bibr" target="#b18">[19]</ref> , and mixed anxiety disorders <ref type="bibr" target="#b19">[20]</ref> .</s></p><p><s>A unique aspect of ACT is its focus on helping patients learn to interact more flexibly with their symptoms (e.g., simply observe them as opposed to trying to eliminate them) and to continue pursuing their values and life goals even in the presence of symptoms <ref type="bibr" target="#b15">[16]</ref> .</s><s>ACT is therefore especially suitable to help treatmentresistant patients, precisely because the possibility that symptoms may persist has been elegantly integrated into its treatment rationale.</s><s>Accordingly, this therapy helps patients abandon their longstanding, unsuccessful struggle with their symptoms.</s><s>This stance allows for the possibility of meaningfully improving patients' lives, even when symptoms persist, and suggests that ACT could be a particularly efficacious and viable treatment option for patients who did not respond to state-of-the-art treatments.</s></p><p><s>In this study, we aimed to test the efficacy of an ACT intervention for patients with treatment-resistant primary PD/A.</s><s>We hypothesized that (1) the ACT treatment group would report a significantly greater reduction in symptoms and an increase in functioning compared to the patients on the waiting list (WL; hypothesis 1), (2) treatment gains would be stronger in ACTspecific processes (i.e., acceptance, defusion, mindfulness) than in panic disorder-specific processes or more general symptom measures (hypothesis 2); and (3) treatment gains would be maintained over 6 months (hypothesis 3).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head><p><s>Please see the online supplementary material (for all online suppl.</s><s>material, see www.karger.com/doi/10.1159/000370162)</s><s>for details on Methods and Results.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Inclusion Criteria</head><p><s>Inclusion criteria were a reliable diagnosis of PD/A, age between 18 and 65 years, a Mobility Inventory (MI) score ≥ 1.5 <ref type="bibr" target="#b20">[21]</ref> , a Clinical Global Impression (CGI) scale score ≥ 4 ('moderately ill') <ref type="bibr" target="#b21">[22]</ref> , and informed consent.</s><s>Additionally, all patients were required to have had one or more previous courses of psychological and/or pharmacological treatment consistent with state-of-the-art practice.</s><s>For psychotherapy, this was defined as ≥ 20 sessions of empirically supported treatments in which all patients had received interventions inherent to these treatments, such as exposure in situ, interoceptive exposure, cognitive restructuring, etc.</s></p><p><s>(n = 38, 88.4%).</s><s>For pharmacology, this was defined as intake of an approved drug at least at the minimum dosage and length as recommended by national and international therapy guidelines <ref type="bibr" target="#b22">[23,</ref><ref type="bibr" target="#b23">24]</ref> (n = 14, 32.6%).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Exclusion Criteria</head><p><s>Exclusion criteria were inadequate previous treatment, concurrent psychotherapy, and diagnoses of alcohol dependence, bipolar disorder, psychotic or eating disorders, benzodiazepine or other drug dependence.</s><s>Patients who were actively suicidal were also excluded.</s><s>If patients were taking psychopharmacological agents, they had to agree not to change the dose during the trial.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Design</head><p><s>This was a randomized, WL-controlled clinical trial conducted in Germany between June 2010 and June 2012, with the final follow-up assessment in December 2012.</s><s>Patients and assessors were blinded to the hypotheses.</s><s>Patients were randomized to either immediate treatment (n = 33) or a 4-week WL (n = 10).</s><s>For ethical reasons, patients from the WL were offered treatment immediately after the 4-week waiting period (delayed treatment; n = 8).</s><s>Patients did not receive any treatment during the follow-up period, and a total of 51 cases were included in the analysis ( fig. <ref type="figure">1</ref> ).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Randomization</head><p><s>An independent statistician randomly allocated patients to immediate treatment or WL with a 3: 1 ratio .</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Intervention</head><p><s>A manual of ACT for anxiety disorders <ref type="bibr" target="#b24">[25]</ref> was adapted for this trial.</s><s>This manual was already successfully employed in a large randomized clinical trial comparing ACT and CBT <ref type="bibr" target="#b19">[20]</ref> .</s><s>The brief treatment consisted of eight sessions administered twice weekly over 4 weeks.</s><s>The sessions lasted between 90 and 120 min.</s><s>ACT is a behavioral treatment with the aim of promoting psychological flexibility and consists of six processes: acceptance, present moment awareness, defusion, self-as-context (observer perspective), value clarification, and committed action.</s><s>Patients worked towards becoming more aware and accepting of anxiety and other uncomfortable emotions and experiences.</s><s>This stance was adopted so that they could more willingly engage in important aspects of their life, irrespective of the presence of uncomfortable emotions and thoughts <ref type="bibr" target="#b26">[27]</ref> .</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Therapists</head><p><s>Therapists were graduate students of a CBT university training center who were well trained and had experience in CBT but had no prior experience treating patients with ACT.</s><s>Therapists were</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Treatment Integrity</head><p><s>All treatment sessions were videotaped, and 19.7% (60/305) of all conducted sessions were analyzed for treatment adherence and therapist competency.</s><s>The ratings were made by one of the manual developers (G.E.) who was not involved in the study management or clinical supervision.</s><s>Ratings were made using the Drexel University ACT/CT Therapist Adherence and Competence Rating Scale <ref type="bibr" target="#b27">[28]</ref> .</s><s>On a scale from 1 (poor) to 5 (excellent), therapists demonstrated very good levels on items measuring (a) knowledge (mean ± SD, 3.9 ± 1.1), (b) skill (3.7 ± 1.4), (c) overall adherence to the manual (4.0 ± 1.3), and (4) overall performance (3.9 ± 1.4).</s><s>Additionally, therapists were judged to have very good relationships with the patients (4.1 ± 0.9).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Assessors</head><p><s>Assessors were blinded to the treatment conditions.</s><s>Before the study, assessors completed a 3-day training, testing, and subsequent certification of the assessment procedures.</s><s>Regular supervision was conducted to maintain consistent strategies across assessors and questions.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Assessment</head><p><s>Patients completed measurements at baseline, post-treatment, and after 6 months of follow-up (FU-6).</s><s>The primary outcome measures included overall panic and agoraphobia symptomatology (Panic Agoraphobia Scale, PAS <ref type="bibr" target="#b28">[29,</ref><ref type="bibr">30]</ref> ), global clinical impression and functioning (CGI <ref type="bibr" target="#b31">[31]</ref> ), and agoraphobic avoidance (MI <ref type="bibr" target="#b32">[32]</ref> ).</s></p><p><s>Diagnoses were derived by the CIDI and validated by expert clinicians <ref type="bibr" target="#b33">[33]</ref><ref type="bibr" target="#b34">[34]</ref><ref type="bibr" target="#b35">[35]</ref><ref type="bibr" target="#b36">[36]</ref><ref type="bibr" target="#b37">[37]</ref><ref type="bibr" target="#b38">[38]</ref> .</s><s>Additional measures targeting three areas were included: (1) panic-specific processes, (2) general symptomatology, and (3) ACT-specific processes.</s><s>First, panic-specific processes were included that have been found to mediate other forms of CBT for PD/A and that are commonly used in the assessment and treatment of PD/A.</s><s>These included: fear related to bodily sensations (Bodily Sensations Questionnaire, BSQ <ref type="bibr" target="#b39">[39]</ref> ), the Agoraphobic Cognitions Questionnaire (ACQ <ref type="bibr" target="#b39">[39]</ref> ), and the Anxiety Sensitivity Index (ASI <ref type="bibr" target="#b40">[40]</ref> ).</s><s>Second, standard measures of more general anxiety and depression were assessed, including the Hamilton Anxiety Rating Scale (SIGH-A <ref type="bibr" target="#b21">[22]</ref> ), the Beck Depression Inventory (BDI-II <ref type="bibr" target="#b41">[41]</ref> ), and the Beck Anxiety Inventory (BAI <ref type="bibr" target="#b42">[42]</ref> ).</s><s>Finally, measures for specific processes assumed to be active in ACT were difficulty with emotional regulation (Difficulty with Emotion Regulation Scale, DERS <ref type="bibr" target="#b43">[43]</ref> ), acceptance/thought suppression (White Bear Suppression Inventory, WBSI <ref type="bibr" target="#b44">[44]</ref> ), mindfulness (Kentucky Inventory of Mindfulness Skills, KIMS <ref type="bibr" target="#b45">[45]</ref> ), and defusion (Believability in Anxious Feelings and Thoughts Questionnaire, BAFT <ref type="bibr" target="#b46">[46]</ref> ) .</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical Analysis Hypothesis 1 (Efficacy)</head><p><s>For all primary and secondary outcomes, hypothesis 1 was tested using ANCOVA with baseline outcome values as covariates.</s><s>For each comparison, the ACT treatment group was compared to the WL in terms of post-treatment.</s><s>Analyses were run both for treatment completers and intent to treat following multiple imputations <ref type="bibr" target="#b47">[47]</ref> .</s><s>Only results based on completers are reported here because all outcomes were comparable (online suppl.</s><s>material).</s><s>Preliminary analyses found no differences in any of the outcome analyses between patients who received immediate treatment and those who first went through the WL, nor were there differences between patients with and those without previous pharmacological treatment.</s></p><p><s>Hypothesis 2 (Differential Response across Disorder-Specific Processes, General Symptoms, and ACT-Specific Processes) We set up a multivariate random intercept model of the combined secondary outcomes to test whether treatment gains would be stronger in ACT-specific processes (i.e., DERS, WBSI, KIMS, and BAFT) than in panic disorder-specific process measures (i.e., BSQ, ACQ, and ASI) or in more general symptom measures (i.e., SIGH-A, BDI-II, and BAI).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Hypothesis 3 (Treatment Gain and Maintenance)</head><p><s>To test hypotheses 2 and 3, we used a linear mixed model <ref type="bibr" target="#b48">[48]</ref> with a random intercept, assuming equal covariances among the three time points.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Response Rate</head><p><s>Consistent with previous research, response was defined as ≤18 ('mild' or less) on the PAS and 'mild' or less on the CGI <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b28">29,</ref><ref type="bibr">30]</ref> .</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sample Characteristics and Randomization Check</head><p><s>The participants were 43 patients diagnosed with primary PD/A.</s><s>They were largely female (69.8%), with an average age of 36.9 years.</s><s>In addition to PD/A, patients endorsed 2.0 comorbid disorders on average.</s><s>The average number of previous therapies was substantial: mean = 42.3,</s><s>median = 25.0 psychotherapy sessions 1 and 2.1 valid psychopharmacological agents ( table <ref type="table" target="#tab_0">1</ref> ).</s><s>No significant differences were observed between the ACT and the WL group at baseline on any outcome measure.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Attrition</head><p><s>Among the 51 cases, 46 (90.2%) completed post-assessment.</s><s>Among the 41 patients who began treatment, 37 (90.2%) completed all eight sessions ( fig. <ref type="figure">1</ref> ) and 1 (2.4%) dropped out after baseline, but prior to the first session.</s><s>Three patients (7.3%) received a partial dose of therapy.</s><s>Attrition was unrelated with any particular element of the treatment, as the dropouts during treatment occurred once following sessions 1, 3, and 5.</s><s>One patient attended all eight sessions, but did not complete post-assessment.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Adverse Events</head><p><s>The patients did not report any adverse events during the treatment or during the FU-6 period.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Treatment Efficacy (ACT vs. WL: Hypothesis 1)</head><p><s>Comparisons between the ACT and the WL group were made only at post-treatment due to the study design.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Primary Outcomes</head><p><s>As expected, the ACT group improved significantly more than the WL group in terms of panic/agoraphobic symptoms (PAS: d = 0.72) and general functioning (CGI: d = 0.89) ( table <ref type="table" target="#tab_1">2</ref> ).</s><s>Despite a medium effect size, the comparison ACT/WL was nonsignificant on the MI (d = 0.50).</s><s>Results based on multiple imputation resulted in comparable values (see online suppl.</s><s>material).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Secondary Outcomes</head><p><s>The secondary outcome measures targeted three areas: PD/A-specific factors, general symptoms, and ACT-specific process measures.</s><s>With the exception of two PD/Aspecific measures (ACQ and ASI), the ACT group performed significantly better than the WL group on all secondary measures ( fig. <ref type="figure" target="#fig_1">2</ref> ).</s><s>Whereas the difference between the ACT and the WL group resulted in small-to-medium effects for the panic-specific factors of ACQ and ASI, comparisons between the groups resulted in medium-tolarge effects for general symptoms, and large-to-very large effects for ACT-specific process measures.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Differential Response across Processes and Symptoms (Hypothesis 2)</head><p><s>The interaction between treatment group and differential category was highly significant (likelihood ratio = 14.6, p &lt; 0.001).</s><s>Thus treatment group results were highest for the category ACT-specific (-1.08,</s><s>SE = 0.23), followed by panic-specific (-0.61,</s><s>SE = 0.22), and general symptoms (-0.45,</s><s>SE = 0.22).</s><s>Differences for these effects  were significant for ACT-specific versus panic-specific and ACT-specific versus general symptoms, but not for panic-specific versus general symptoms.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Within-Group Change and Maintenance of Gains following Treatment (Hypothesis 3).</head><p><s>Across all primary and secondary variables, values at FU-6 were statistically improved compared to baseline.</s><s>They continued to significantly improve between posttreatment and FU-6 (p &lt; 0.05) for panic symptoms and were nearly significant for MI (p = 0.06) and CGI (p = 0.06) ( fig. <ref type="figure" target="#fig_2">3</ref> ).</s><s>No variable demonstrated statistically significant worsening between post-treatment and FU-6.</s><s>Taken together, these results clearly suggest that treatment gains are maintained for at least 6 months, do not recede, and to some degree continue to improve during this generalization period.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Response Rates</head><p><s>Categorical response rates were calculated at both post-treatment and FU-6.</s><s>At post-treatment, response rates for PD/A symptomatology (PAS) and functioning (CGI) were 70 and 57%, respectively.</s><s>At FU-6, response rates for PD/A symptomatology and functioning were 80 and 52% respectively.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Generalization (Change in Diagnoses)</head><p><s>The number of diagnoses was again calculated at FU-6 in order to test the breadth of the treatment effect.</s><s>The mean number of diagnoses at FU-6 (1.2) was significantly reduced from that at baseline (1.8; t 40 = 2.72, p &lt; 0.01).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>This RCT demonstrated the efficacy of switching to a psychological treatment (ACT) for treatment-resistant patients with PD/A.</s><s>Medium-to-large effects were observed on primary indices of PD/A symptoms and general functioning.</s><s>These effects were significantly superior to those of the WL patients.</s><s>Effects for agoraphobic avoidance were nearly statistically significant in comparison to the WL, with a medium-controlled effect size.</s><s>These improvements were either maintained or improved in the 6 months following treatment.</s><s>These results are promising and suggest a new option for the sizeable minority of treatment-resistant patients <ref type="bibr" target="#b49">[49]</ref><ref type="bibr" target="#b50">[50]</ref><ref type="bibr" target="#b51">[51]</ref> .</s></p><p><s>In the present study, the switch was made to ACT because this therapy specifically aims to alter the struggle with longstanding symptoms by undermining the unnecessary struggle with internal psychological barriers in order to engage with what is important in one's life.</s><s>To test this, we assessed several interrelated clinical processes and compared these across numerous measures.</s><s>Measures assessing ACT-specific constructs showed the largest effects.</s><s>In particular, not suppressing uncomfortable thoughts and emotions (i.e., acceptance) and not taking anxious thoughts and feelings literally (i.e., defusion) showed the largest improvement in comparison to the WL group.</s><s>Large effects were also seen on measures of mindfulness and general difficulty with unhelpful emotional regulation.</s><s>Taken as a whole, these results are consistent with one of the central tenets of ACT, namely that directly targeting these core processes leads to beneficial changes in patients' lives.</s><s>These data support this interpretation insofar as the patients reported increases in functioning despite some rest symptomatology.</s><s>The pattern across constructs was particularly revealing.</s><s>For instance, although anxiety sensitivity (ASI) is one of the most consistently identified mediators of treatment in PD, the effect in comparison to the WL was small and nonsignificant.</s><s>In contrast, when asked about the believability of the same type of items (BAFT), the change in comparison to the WL resulted in the largest effect size.</s><s>Of clinical importance, this suggests that the content of the occurrence of evaluative anxiety statements is not as important as whether someone believes the thoughts.</s><s>Consistent with this interpretation, the ACT process measures were consistently in the range of large effects, whereas traditional panic-related processes and general symptomatology were in the small-to-medium range, respectively.</s><s>Taken as a whole, these results suggest that the psychological processes targeted by ACT processes have indeed been successfully changed.</s></p><p><s>As observed in this study, treatment gains were clearly maintained and continued to improve.</s><s>Although the improvement was not always significant, all tested variables showed at least some improvement and none demonstrated deterioration.</s><s>Furthermore, the number of comorbid diagnoses reduced significantly from baseline to follow-up, even though they were not targeted.</s><s>Results from this study are consistent with studies showing that acceptance-and mindfulness-based interventions achieved better outcomes for patients with comorbidity, whereas traditional CBT fared better for patients with only one disorder <ref type="bibr" target="#b52">[52]</ref> .</s><s>This is consistent with evidence observed in a noncontrolled group of depressed patients treated using mindfulness <ref type="bibr" target="#b53">[53]</ref> .</s><s>As the current sample was highly comorbid and treatment-resistant, mindfulness-and acceptance-based approaches may be especially effective in this population.</s><s>The present results are also consistent with a small study of patients who did not adequately respond to exposure therapy, but showed improvement after focusing on well-being <ref type="bibr" target="#b54">[54]</ref> .</s></p><p><s>Of clinical importance, the dropout rate in this study (9%) was much lower than that in other treatment outcome studies.</s><s>For example, two large studies of traditional CBT for panic disorder and agoraphobia reported dropout rates ranging between 19.6% <ref type="bibr" target="#b10">[11]</ref> and 28% <ref type="bibr" target="#b0">[1]</ref> , with similar rates reported for CBT across anxiety disorders (23%) <ref type="bibr" target="#b55">[55]</ref> and in pharmacological treatments for panic disorder (19.8%) <ref type="bibr" target="#b56">[56]</ref> .</s><s>We have no way of ascertaining the exact reason for the low attrition rate in this study.</s><s>We suspect, however, that switching to the ACT content combined with the condensed format of our treatment program (i.e., two clearly structured sessions per week with regular homework assignments) had a favorable impact.</s></p><p><s>This study has several limitations.</s><s>First, the sample size was small and may have led to increased type II error.</s><s>This concern is mitigated by the medium-to-large effect sizes observed.</s><s>Nevertheless, we concentrated our interpretation on effect sizes.</s><s>Second, we cannot exclude the possibility that nonspecific factors were responsible for the observed changes as we were unable to include a clinical control group with a different treatment.</s><s>Although the pattern of results, especially the stronger responses in ACT-specific measures, mitigates this concern somewhat future research will need to address the specificity of these findings.</s><s>Third, including patients into the ACT treatment after they had been on the WL could have potentially led to a systematic bias.</s><s>As suggested by our preliminary analyses, this did not appear to have an effect on the outcomes.</s><s>Fourth, we were reliant on patients to provide some details about their treatment history.</s><s>To assist them and to guard against imprecise reporting, we provided a list of interventions and techniques commonly used in empirically supported psychotherapy and other techniques and asked them to endorse what they had already experienced.</s><s>For patients who had had prior pharmacotherapy, we compared their medication against na-tional treatment guidelines.</s><s>Further, we compared those patients for whom we had very detailed information from our previous controlled trial <ref type="bibr" target="#b49">[49]</ref> against the others.</s><s>No differences were found for any of these comparisons, suggesting that treatment history was not a confounder and that we only treated nonresponders whose previous treatment had been adequate.</s><s>Fifth, this study only examined patients with primary PD/A.</s><s>Although these patients were highly comorbid and the treatment addressed emotions in general, examination of other disorders is needed to determine the limits of generalizability.</s><s>Sixth, we used therapists in training who may have a particularly high therapy alliance.</s><s>Finally, although the 6-month assessment results are promising, even longer follow-ups are needed to determine if the skills learned during the treatment remain useful during additional challenges that are surely to arise in their lives.</s></p><p><s>Notwithstanding these limitations, we conclude that switching to psychotherapy can effectively treat treatment-resistant PD/A patients, particularly if the new treatment adopts a different approach than the original therapy and if it is administered in a structured manner that also requires the active involvement of patients <ref type="bibr" target="#b13">[14,</ref><ref type="bibr" target="#b14">15]</ref> .</s><s>We agree that avoidance does indeed matter in treatment-resistant patients <ref type="bibr" target="#b57">[57]</ref> , and ACT appears to be a viable method to address both the numerous manifestations of subtle and overt experiential avoidance in cases that do not otherwise respond to first-line treatments.</s><s>Further tests in other treatment-resistant populations are clearly needed and future research should continue to develop and refine interventions for this population.</s></p><p><s>speaker honoraria from Astra Zeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Co., Lundbeck, Pfizer, Wyeth, and UCB.</s><s>He was a consultant for Actelion.</s><s>Educational grants were given by the Stifterverband für die Deutsche Wissenschaft, the Berlin Brandenburgische Akademie der Wissenschaften, the Boehringer Ingelheim Fonds, the Eli Lilly International Foun-dation, Janssen-Cilag, Pfizer, and Eli Lilly and Co.</s><s>Dr. H.-U. Wittchen is or has been on advisory boards of Servier, Pfizer, and Lundbeck.</s><s>Via his university, he also has received grant support by Novartis, Lundbeck, and Pfizer.</s><s>Travel compensation for scientific meetings were received from Servier, Pfizer, Lundbeck, and Novartis.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>3 Fig. 1 .</head><label>31</label><figDesc><div><p><s>Fig. 1.</s><s>Flowchart of patients included in the study.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 2 .</head><label>2</label><figDesc><div><p><s>Fig. 2. Controlled effect size of secondary outcome measures at post-treatment (vs.</s><s>WL group).</s><s>All effects were significantly different (p &lt; 0.05) from the WL group, except for the white bars.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 3 .</head><label>3</label><figDesc><div><p><s>Fig. 3.</s><s>Primary outcome response pattern across baseline, post-treatment, and FU-6.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>Baseline characteristics by treatment condition</s></p></div></figDesc><table><row><cell></cell><cell cols="2">ACT (n = 33) WL (n = 10)</cell></row><row><cell>Age, years</cell><cell>36.7 ± 8.9</cell><cell>37.5 ± 8.9</cell></row><row><cell>Previous sessions</cell><cell>42.6 ± 42.4</cell><cell>41.2 ± 33.4</cell></row><row><cell>Comorbid diagnoses</cell><cell>1.9 ± 3.2</cell><cell>2.3 ± 2.7</cell></row><row><cell>Sex, n (%)</cell><cell></cell><cell></cell></row><row><cell>Male</cell><cell>11 (33.3)</cell><cell>2 (20.0)</cell></row><row><cell>Female</cell><cell>22 (66.7)</cell><cell>8 (80.0)</cell></row><row><cell>Years of education</cell><cell></cell><cell></cell></row><row><cell>8</cell><cell>1 ± 3.0</cell><cell>1 ± 10.0</cell></row><row><cell>10</cell><cell>14 ± 42.4</cell><cell>4 ± 40.0</cell></row><row><cell>12 -13+</cell><cell>13 ± 39.4</cell><cell>2 ± 20.0</cell></row><row><cell>No formal degree</cell><cell>5 ± 15.2</cell><cell>3 ± 30.0</cell></row><row><cell>Living arrangement</cell><cell></cell><cell></cell></row><row><cell>With parents</cell><cell>0</cell><cell>0</cell></row><row><cell>Alone</cell><cell>7 ± 21.2</cell><cell>0</cell></row><row><cell>With partner</cell><cell>20 ± 60.6</cell><cell>6 ± 60.0</cell></row><row><cell>Other</cell><cell>6 ± 18.2</cell><cell>4 ± 40.0</cell></row><row><cell>Employment</cell><cell></cell><cell></cell></row><row><cell>University student</cell><cell>1 ± 3.0</cell><cell>0</cell></row><row><cell>Job training</cell><cell>1 ± 3.0</cell><cell>1 ± 10.0</cell></row><row><cell>Employed</cell><cell>20 ± 60.6</cell><cell>6 ± 60.0</cell></row><row><cell>Unemployed</cell><cell>6 ± 18.2</cell><cell>0</cell></row><row><cell>Other</cell><cell>5 ± 15.2</cell><cell>3 ± 30.0</cell></row><row><cell>Social class</cell><cell></cell><cell></cell></row><row><cell>Lowest</cell><cell>1 ± 3.0</cell><cell>0</cell></row><row><cell>Lower middle</cell><cell>7 ± 21.2</cell><cell>2 ± 20.0</cell></row><row><cell>Middle</cell><cell>19 ± 57.6</cell><cell>4 ± 40.0</cell></row><row><cell>Upper middle</cell><cell>1 ± 3.0</cell><cell>1 ± 10.0</cell></row><row><cell>Upper</cell><cell>0</cell><cell>0</cell></row><row><cell>Marital status</cell><cell></cell><cell></cell></row><row><cell>Married</cell><cell>6 ± 18.2</cell><cell>4 ± 40.0</cell></row><row><cell>Divorced/widowed/separated</cell><cell>5 ± 15.2</cell><cell>0</cell></row><row><cell>Never been married</cell><cell>17 ± 51.5</cell><cell>3 ± 30.0</cell></row><row><cell>Comorbidity, 12-month diagnoses</cell><cell></cell><cell></cell></row><row><cell>Alcohol abuse</cell><cell>1 ± 3.0</cell><cell>0</cell></row><row><cell>Alcohol dependence</cell><cell>0</cell><cell>0</cell></row><row><cell>Generalized anxiety disorder</cell><cell>5 ± 15.2</cell><cell>0</cell></row><row><cell>Social phobia</cell><cell>12 ± 36.4</cell><cell>3 ± 30.0</cell></row><row><cell>Any specific phobia</cell><cell>12 ± 36.4</cell><cell>3 ± 30.0</cell></row><row><cell>Obsessive-compulsive disorder</cell><cell>6 ± 18.2</cell><cell>3 ± 30.0</cell></row><row><cell>Posttraumatic stress disorder</cell><cell>1 ± 3.0</cell><cell>1 ± 10.0</cell></row><row><cell>Major depressive episodes</cell><cell>8 ± 24.2</cell><cell>4 ± 40.0</cell></row><row><cell>Dysthymia</cell><cell>5 ± 15.2</cell><cell>2 ± 20.0</cell></row><row><cell>Pain disorder</cell><cell>7 ± 21.2</cell><cell>2 ± 20.0</cell></row><row><cell>Comorbid diagnoses, number</cell><cell></cell><cell></cell></row><row><cell>None</cell><cell>8 ± 24.2</cell><cell>0</cell></row><row><cell>1 -2</cell><cell>1 5 ± 45.4</cell><cell>5 ± 50.0</cell></row><row><cell>3 -4</cell><cell>6 ± 18.2</cell><cell>4 ± 40.0</cell></row><row><cell>5+</cell><cell>4 ± 12.1</cell><cell>1 ± 10.0</cell></row><row><cell cols="3">Numbers vary across categories due to missing values.</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>Primary outcome variables between group effects at posttreatment</s></p></div></figDesc><table><row><cell></cell><cell cols="2">Difference between ACT</cell><cell cols="3">Difference between group</cell></row><row><cell></cell><cell cols="2">and WL at post-treatment</cell><cell cols="3">effects at post-treatment</cell></row><row><cell></cell><cell>Mean</cell><cell>SE</cell><cell>F</cell><cell>p</cell><cell>d</cell></row><row><cell>PAS</cell><cell>-6.8</cell><cell>3.0</cell><cell>4.99</cell><cell cols="2">0.02 0.72</cell></row><row><cell>CGI</cell><cell>-1.0</cell><cell>0.3</cell><cell>8.20</cell><cell cols="2">0.00 0.89</cell></row><row><cell>MI</cell><cell>-0.3</cell><cell>0.2</cell><cell>2.18</cell><cell cols="2">0.07 0.50</cell></row></table><note><p><s>Psychother Psychosom 2015;84:100-109 DOI: 10.1159/000370162 105</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Psychother Psychosom 2015;84:100-109 DOI: 10.1159/000370162</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="1">Regulations in Germany guarantee patients 25 sessions of short-term empirically supported CBT. Charted psychotherapists administered the therapies with quality controls administered by the regulated German social insurance system.</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>The study was funded by the German Federal Ministry of Education and Research (BMBF; project No. 01GV0615) as part of the BMBF Psychotherapy Research Funding Initiative .</s><s>This study was registered with the trial registration: ISRCTN 12042066.</s><s>We wish to thank the therapists of this study for their dedication throughout the trial, the patients for their trust and the brave steps they took, and Marie-Noëlle Cottens for her assistance in the preparation of the manuscript.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Disclosure Statement</head><p><s>Dr. A.T. <ref type="bibr">Gloster</ref></s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Cognitive-behavioral therapy, imiprami ne, or their combination for panic disorder -a randomized controlled trial</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Barlow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Gorman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Shear</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Woods</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">283</biblScope>
			<biblScope unit="page" from="2529" to="2536" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Psychological well-being and residual symptoms in remitted patients with panic disorder and agoraphobia</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Fava</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Rafanelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ottolini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ruini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Caz Zaro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Grandi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Affect Disord</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="185" to="190" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Novel treatment approaches for refractory anxiety disorders</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Pollack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Otto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Roy-Byrne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Coplan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">O</forename><surname>Rothbaum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Simon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Gorman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Depress Anxiety</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="467" to="476" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Cognitive therapy versus fluvoxamine as a second-step treatment in obsessive-compulsive disorder nonresponsive to first-step behavior therapy</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Van Balkom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Emmelkamp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Eikelenboom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Hoogendoorn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Smit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Van Oppen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychother Psychosom</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="366" to="374" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder</title>
		<author>
			<persName><forename type="first">A</forename><surname>Palatnik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Frolov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Benjamin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Psychopharm</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="335" to="339" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">CBT for pharmacotherapy non-remitters -a systematic review of a next-step strategy</title>
		<author>
			<persName><forename type="first">H</forename><surname>Rodrigues</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Figueira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Goncalves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mendlowicz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Macedo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ventura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Affect Disord</title>
		<imprint>
			<biblScope unit="volume">129</biblScope>
			<biblScope unit="page" from="219" to="228" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Overcoming resistance to exposure in panic disorder with agoraphobia</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Fava</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Savron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zielezny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Grandi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Rafanelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Conti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Psychiatr Scand</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="306" to="312" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Does maintenance CBT contribute to long-term treatment response of panic disorder with or without agoraphobia? A randomized controlled clinical trial</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>White</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Payne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Gorman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Shear</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Woods</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Saksa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Barlow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Consult Clin Psychol</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="47" to="57" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Mediators and mechanisms of change in psychotherapy research</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Kazdin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu Rev Clin Psychol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="1" to="27" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Innovative trends in the design of therapeutic trials in psychopharmacology and psychotherapy</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Fava</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Tomba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Tossani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Prog Neuropsychopharmacol Biol Psychiatry</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="306" to="311" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Gloster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">U</forename><surname>Wittchen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Einsle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Helbig-Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fydrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">O</forename><surname>Hamm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Richter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Alpers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Gerlach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Strohle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kircher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Deckert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Zwanzger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hofler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Arolt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Consult Clin Psychol</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="406" to="420" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Timing matters: mediators of outcomes in cognitive behavioral therapy for panic disorder with agoraphobia depend on the stage of treatment</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Gloster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Klotsche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">U</forename><surname>Wittchen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Helbig-Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Gerlach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Richter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Alpers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kircher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">O</forename><surname>Hamm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ströhle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Deckert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Consult Clin Psychol</title>
		<imprint/>
	</monogr>
	<note>in press</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Maximizing the efficacy of interoceptive exposure by optimizing inhibitory learning: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">B</forename><surname>Deacon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Kemp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Dixon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Sy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">R</forename><surname>Farrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Behav Res Ther</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="588" to="596" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Sequential treatment of mood and anxiety disorders</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Fava</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ruini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Rafanelli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Psychiatry</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="1392" to="1400" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Residual symptoms in depression: an emerging therapeutic target</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Fava</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fabbri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sonino</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Prog Neuropsychopharmacol Biol Psychiatry</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="1019" to="1027" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<monogr>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Hayes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Strosahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Wilson</surname></persName>
		</author>
		<title level="m">Acceptance and Commitment Therapy</title>
				<meeting><address><addrLine>New York</addrLine></address></meeting>
		<imprint>
			<publisher>Guilford Press</publisher>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Acceptance and commitment therapy: model, processes and outcomes</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Hayes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Luoma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Bond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Masuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lillis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Behav Res Ther</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="1" to="25" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Acceptance and commitment therapy for generalized social anxiety disorder -a pilot study</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Dalrymple</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Herbert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Behav Modif</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="543" to="568" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Acceptance and commitment therapy for anxiety disorders: three case studies exemplifying a unified treatment protocol</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">H</forename><surname>Eifert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Forsyth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Arch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Espejo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Keller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Langer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cogn Behav Pract</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="368" to="385" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Randomized clinical trial of cognitive behavioral therapy (CBT) versus acceptance and commitment therapy (ACT) for mixed anxiety disorders</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Arch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">H</forename><surname>Eifert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Davies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Plumb</forename><surname>Vilardaga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Rose</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Craske</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Consult Clin Psychol</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="750" to="765" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">The mobility inventory for agoraphobia</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Chambless</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Caputo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Jasin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Gracely</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Williams</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Behav Res Ther</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="35" to="44" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A)</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Shear</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Vander</forename><surname>Bilt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Endicott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lydiard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Otto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Pollack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Chandler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Ali</forename><forename type="middle">A</forename><surname>Frank</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Depress Anxiety</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="166" to="178" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">WFSBP Task Force on Treatment Guidelines for Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders: World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders -first revision</title>
		<author>
			<persName><forename type="first">B</forename><surname>Bandelow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zohar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hollander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kasper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Moller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Allgulander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ayuso-Gutierrez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Baldwin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bunevicius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Cassano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Fineberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Gabriels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Hindmarch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kaiya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Klein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lader</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Lecrubier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Lepine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Liebowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Lopez-Ibor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Marazziti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Miguel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Oh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Preter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rupprecht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Starcevic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Stein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Van Ameringen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Vega</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">World J Biol Psychiatry</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="248" to="312" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Arzneimittelkommission der deutschen Ärzteschaft: Empfehlungen zur Therapie von Angst-und Zwangsstörungen. Arzneiverordnung in der</title>
	</analytic>
	<monogr>
		<title level="j">Praxis</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1" to="22" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note>suppl</note>
</biblStruct>

<biblStruct xml:id="b24">
	<monogr>
		<title level="m" type="main">Acceptance and Commitment therapy for Anxiety Disorders: A Practitioner&apos;s Treatment Guide to Using Mindfulness, Acceptance, and Values-Based Behavior Change Strategies</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">H</forename><surname>Eifert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Forsyth</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2005">2005</date>
			<publisher>New Harbinger Publications</publisher>
			<pubPlace>Oakland</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Assessing psychological flexibility: what does it add above and beyond existing constructs?</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Gloster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Klotsche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Chaker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">V</forename><surname>Hummel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hoyer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychol Assess</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="970" to="982" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<monogr>
		<title level="m" type="main">Exposure Therapy: Rethinking the Model -Refining the Method</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Gloster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">V</forename><surname>Hummel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Lyudmirskaya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hauke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Sonntag</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2012">2012</date>
			<publisher>Springer Science + Business Media</publisher>
			<biblScope unit="page" from="127" to="152" />
			<pubPlace>New York</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<monogr>
		<title level="m" type="main">Validation of the Drexel University ACT/tCBT Adherence and Competence Rating Scale: Revised for Use in a Clinical Population</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Mcgrath</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2012">2012</date>
			<pubPlace>Philadelphia</pubPlace>
		</imprint>
		<respStmt>
			<orgName>Drexel University</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<monogr>
		<author>
			<persName><forename type="first">B</forename><surname>Bandelow</surname></persName>
		</author>
		<title level="m">Panik-und Agoraphobieskala (PAS)</title>
				<meeting><address><addrLine>Göttingen, Hogrefe</addrLine></address></meeting>
		<imprint>
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title/>
		<idno type="DOI">10.1159/000370162</idno>
	</analytic>
	<monogr>
		<title level="j">Psychother Psychosom</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="100" to="109" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale</title>
		<author>
			<persName><forename type="first">B</forename><surname>Bandelow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int Clin Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="73" to="81" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">W</forename><surname>Guy</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1976">1976</date>
		</imprint>
		<respStmt>
			<orgName>ECDEU Assessment Manual for Psychopharmacology. Rockville, Department of Health, Education, and Welfare</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">The mobility inventory for agoraphobia</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Chambless</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Caputo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Jasin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Gracely</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Williams</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Behav Res Ther</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="35" to="44" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">An overview of the Composite International Diagnostic Interview (CIDI)</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Essau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">U</forename><surname>Wittchen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Methods Psychiatr Res</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="79" to="85" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Structure, content and reliability of the Munich Composite International Diagnostic Interview (M-CIDI) substance use sections</title>
		<author>
			<persName><forename type="first">G</forename><surname>Lachner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">U</forename><surname>Wittchen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Perkonigg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Holly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Schuster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Wunderlich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Turk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Garczynski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Pfister</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Addict Res</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="28" to="41" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">To what degree does the Composite International Diagnostic Interview (CIDI) correctly identify DSM-IV disorders? Testing validity issues in a clinical sample</title>
		<author>
			<persName><forename type="first">V</forename><surname>Reed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Gander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Pfister</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Steiger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sonntag</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Trenkwalder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sonntag</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Hundt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">U</forename><surname>Wittchen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Methods Psychiatr Res</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="142" to="155" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">The composite international diagnostic interview -an epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">N</forename><surname>Robins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">U</forename><surname>Wittchen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Helzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Babor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Burke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Farmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jablenski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pickens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Regier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sartorius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Towle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Gen Psychiatry</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="1069" to="1077" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Reliability and validity studies of the WHO -Composite International Diagnostic Interview (CIDI) -a critical review</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">U</forename><surname>Wittchen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Psychiatr Res</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="57" to="84" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<monogr>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">U</forename><surname>Wittchen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Pfister</surname></persName>
		</author>
		<title level="m">Instruktionsmanual zur Durchführung von Dia-X Interviews. Frankfurt, Swets and Zeitlinger</title>
				<imprint>
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Assessment of fear of fear in agoraphobics -the body sensations questionnaire and the agoraphobic cognitions questionnaire</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Chambless</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Caputo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gallagher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Consult Clin Psychol</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="1090" to="1097" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Anxiety sensitivity, anxiety frequency and the prediction of fearfulness</title>
		<author>
			<persName><forename type="first">S</forename><surname>Reiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Peterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Gursky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Mcnally</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Behav Res Ther</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="1" to="8" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<monogr>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Beck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Steer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Brown</surname></persName>
		</author>
		<title level="m">BDI-II, Beck Depression Inventory: Manual. San Antonio, Psychological Corporation</title>
				<imprint>
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<monogr>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Beck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Steer</surname></persName>
		</author>
		<title level="m">Manual for the Beck Anxiety Inventory. San Antonio, Psychological Corporation</title>
				<imprint>
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Multidimensional assessment of emotion regulation and dysregulation: development, factor structure, and initial validation of the difficulties in emotion regulation scale</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Gratz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Roemer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Psychopathol Behav</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="41" to="54" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Chronic thought suppression</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Wegner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Zanakos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pers</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="615" to="640" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Assessment of mindfulness by self-report -the Kentucky inventory of mindfulness skills</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Baer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">T</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Allen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Assessment</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="191" to="206" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">The Believability of Anxious Feelings and Thoughts Questionnaire (BAFT): a psychometric evaluation of cognitive fusion in a nonclinical and highly anxious community sample</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">N</forename><surname>Herzberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Sheppard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Forsyth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Crede</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Earleywine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">H</forename><surname>Eifert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychol Assess</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="877" to="891" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">MICE: Multivariate imputation by chained equations in R</title>
		<author>
			<persName><forename type="first">S</forename><surname>Van Buuren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Groothuis-Oudshoorn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Stat Softw</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="1" to="67" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<monogr>
		<title level="m" type="main">Mixed-Effects Models in S and S-Plus</title>
		<author>
			<persName><forename type="first">J</forename><surname>Pinheiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bates</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2002">2002</date>
			<publisher>Springer</publisher>
			<pubPlace>New York</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Long-term stability of cognitive behavioral therapy effects for panic disorder with agoraphobia: a two-year follow-up study</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Gloster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hauke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hofler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Einsle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fydrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hamm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sthrohle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">U</forename><surname>Wittchen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Behav Res Ther</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="830" to="839" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Long-term outcome of eight clinical trials of CBT for anxiety disorders: symptom profile of sustained recovery and treatment-resistant groups</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Durham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Higgins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Chambers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Swan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mgt</forename><surname>Dow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Affect Disord</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="page" from="875" to="881" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">The hidden third: improving outcome in treatment-resistant depression</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Schlaepfer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Agren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Monteleone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gasto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Pitchot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Rouillon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Nutt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kasper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="587" to="602" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Which treatment worked better for whom? Moderators of group cognitive behavioral therapy versus adapted mindfulness based stress reduction for anxiety disorders</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Arch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Ayers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Behav Res Ther</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="434" to="442" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Treatment-resistant depressed patients show a good response to mindfulness-based cognitive therapy</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Kenny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jmg</forename><surname>Williams</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Behav Res Ther</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="617" to="625" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Well-being therapy: conceptual and technical issues</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Fava</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychother Psychosom</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="171" to="179" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Cognitive-behavioral therapy for adult anxiety disorders: a metaanalysis of randomized placebo-controlled trials</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Hofmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jaj</forename><surname>Smits</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Psychiatry</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="621" to="632" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">A metaanalysis of treatment outcome for panic disorder</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Gould</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Otto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Pollack</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Psychol Rev</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="819" to="844" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Non-adherence and non-response in the treatment of anxiety disorders</title>
		<author>
			<persName><forename type="first">S</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Abramowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Mckay</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Anxiety Disord</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="583" to="589" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
